EpiPredict scientists discover novel mechanism behind underlying breast cancer hormone therapy resistance

2017-01-31

Researchers discover novel mechanism behind underlying breast cancer hormone therapy resistance. An international team of researchers, including EpiPredict researchers, has discovered a mechanism that makes a common type of breast cancer cells resistant to a specific form of hormone treatment. Their findings have been published online on Nature Genetics, 23 January 2017. doi:10.1038/ng.3773